Evidence map›Paper›PMID 33603238›Full record

ArticleNature nanotechnology2021

Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo.

Mingjing Cao, Rong Cai, Lina Zhao, Mengyu Guo, Liming Wang, Yucai Wang, Lili Zhang, Xiaofeng Wang, Haodong Yao, Chunyu Xie and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
28.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 252 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Engineered MoSNanomaterials (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Functional Polarization of Liver Macrophages by Glyco Gold Nanoparticles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Mingjing Cao *CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0003-1741-3808
Rong Cai *CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0001-6793-5765
Lina Zhao *CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0002-9796-0221
Mengyu Guo *CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0002-9953-0073
Liming WangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0003-1382-9195
Yucai WangHefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Biomedical Engineering, Faculty of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.ORCID http://orcid.org/0000-0001-6046-2934
Lili ZhangShanghai Synchrotron Radiation Facility, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0002-7385-2445
Xiaofeng WangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0002-0042-6285
Haodong YaoCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0001-5959-8594
Chunyu XieCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
Yalin CongCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0003-4709-4908
Yong GuanNational Synchrotron Radiation Laboratory, University of Science and Technology of China, Hefei, China.ORCID http://orcid.org/0000-0002-7596-3114
Xiayu TaoNational Synchrotron Radiation Laboratory, University of Science and Technology of China, Hefei, China.ORCID http://orcid.org/0000-0001-8487-5047
Yaling WangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0002-5845-5150
Shaoxin XuCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0001-8723-9433
Ying LiuCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0002-6540-0473
Yuliang ZhaoCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.ORCID http://orcid.org/0000-0002-9586-9360
Chunying ChenCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China. chenchy@nanoctr.cn.ORCID http://orcid.org/0000-0002-6027-0315
National Center for Nanoscience and Technology · CNChinese Academy of Sciences · CNUniversity of Science and Technology of China · CNNational Engineering Research Center for Nanotechnology · CNSino-Danish Centre for Education and Research · CNShanghai Institute of Applied Physics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many nanoscale biomaterials fail to reach the clinical trial stage due to a poor understanding of the fundamental principles of their in vivo behaviour. Here we describe the transport, transformation and bioavailability of MoS

Indexed as

Administration, IntravenousAnimalsApolipoproteins EBiological AvailabilityBiotransformationBlood ProteinsDisulfidesFemaleLiverMacrophagesMiceMice, Inbred BALB CMice, TransgenicMolecular Dynamics SimulationMolybdenumNanostructuresApoe protein, mouseApolipoproteins EBlood ProteinsDisulfidesMolybdenummolybdenum disulfideProtein CoronaSerum Albumin, Human

Identifiers

PMID33603238
OpenAlexW3133195727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.